OUR STUDIES

Investigating the Therapeutic Effect of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD).

Phase 2 trial investigating the effect of two doses of psilocybin for the treatment of PTSD. All study assessments and interventions occur in Windsor, Nova Scotia. If you or someone you know has treatment-resistant PTSD and might be eligible to participate please fill out our short survey.

​